Live
- BJP releases ‘charge sheet’ against BJD govt
- District Nodal Officer Venkataramana announced the intermediate results
- She team that stopped child marriages
- Medical devices sector needs separate rules, says industry body AiMeD
- Andhra Paper declares lockout
- Opposition INDIA bloc working on 'one year, one PM' formula: PM Modi
- Delhi HC quashes FIR for outraging woman's modesty, orders man to assist Traffic Police for a month as settlement
- 'Apologise to families of farmers who committed suicide in Vidarbha', Amit Shah dares Sharad Pawar
- SC Collegium recommends appointment of a permanent judge in Chhattisgarh HC, extension of term of two judges
- U20 Men's football nationals: Telangana, Sikkim earn full points with easy win
Hyderabad: Second dose pending in stage-2 trials of Covaxin at NIMS
Hyderabad: Second dose pending in stage-2 trials of Covaxin at NIMS
Highlights
While Bharat Biotech is making arrangements for Stage-3 clinical trials of Covaxin on over 25,000 to 30,000 persons from October, stage-2 trials at NIMS are set to complete in two weeks' time.
Hyderabad: While Bharat Biotech is making arrangements for Stage-3 clinical trials of Covaxin on over 25,000 to 30,000 persons from October, stage-2 trials at NIMS are set to complete in two weeks' time.
Fifty volunteers have been administered the first dose of the vaccine with the second dose to be given after 21 days. Already ten days have passed since the first dose was given, stated a doctor involved in the process.
Meanwhile, Telangana reported 2,296 new cases pushing the total infections so far to 1.77 lakh. Ten patients have succumbed to the virus taking the deceased count to 1062.
Next Story
ADVERTISEMENT
